Published in Proc Natl Acad Sci U S A on August 15, 1993
Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun (1996) 2.02
Group A Streptococcus intranasal infection promotes CNS infiltration by streptococcal-specific Th17 cells. J Clin Invest (2015) 0.90
Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J Exp Med (1995) 0.89
Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Infect Immun (1998) 0.83
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol (1967) 9.74
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A (1989) 4.66
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell (1990) 4.47
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol (1990) 4.39
Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis (1985) 3.66
A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med (1989) 3.58
Transferrin receptor on endothelium of brain capillaries. Nature (1984) 3.37
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med (1991) 2.79
Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J Exp Med (1991) 2.52
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med (1989) 2.18
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A (1991) 1.85
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Morphology of blood-brain interfaces. Exp Eye Res (1977) 1.65
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Identification of a cell surface protein complex mediating phorbol ester-induced adhesion (binding) among human mononuclear leukocytes. Scand J Immunol (1985) 1.40
The blood-brain barrier. Sci Am (1986) 1.38
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Primary culture of capillary endothelium from rat brain. In Vitro (1981) 1.30
Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A (1987) 1.27
Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res (1990) 1.24
Brain induces the expression of an early cell surface marker for blood-brain barrier-specific endothelium. EMBO J (1986) 1.22
Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol (Paris) (1991) 1.13
The glucose transporter of the human brain and blood-brain barrier. Ann Neurol (1988) 1.12
The role of complement in inflammation during experimental pneumococcal meningitis. Microb Pathog (1986) 1.08
Neurothelin: an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons. J Cell Biol (1990) 0.95
The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci Lett (1991) 0.91
A monoclonal antibody to the endothelium of rat brain microvessels. Brain Res (1986) 0.82
Leucocyte recruitment and inflammation in the CNS. Trends Neurosci (1992) 0.82
Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care (2000) 3.75
Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69
Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol (1999) 3.56
A technique for accessory cervical heart transplantation in rabbits and rats. Acta Pathol Microbiol Scand A (1971) 2.55
T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun (1991) 2.43
Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol (1985) 2.31
Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect Immun (1993) 2.27
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Lancet (1984) 2.16
Conductivity tensor mapping of the human brain using diffusion tensor MRI. Proc Natl Acad Sci U S A (2001) 2.08
Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol (1992) 2.05
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A (1991) 1.85
Evidence for dispensable sequences inserted into a nucleotide fold. Science (1987) 1.85
Antibody responses against Mycobacterium tuberculosis in 11 strains of inbred mice: novel monoclonal antibody specificities generated by fusions, using spleens from BALB.B10 and CBA/J mice. Infect Immun (1988) 1.70
Neuromagnetic source imaging with FOCUSS: a recursive weighted minimum norm algorithm. Electroencephalogr Clin Neurophysiol (1995) 1.68
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
A covalent adduct between the uracil ring and the active site of an aminoacyl tRNA synthetase. Nature (1982) 1.65
Understanding structural relationships in proteins of unsolved three-dimensional structure. Proteins (1990) 1.65
Light-induced calcium fluxes from outer segment layer of vertebrate retinas. Nature (1980) 1.63
Regulatory effect of interferon on T cells in vitro. J Immunol (1976) 1.62
Immunity against diphtheria 25-30 years after primary vaccination in childhood. Lancet (1985) 1.54
The influence of brain tissue anisotropy on human EEG and MEG. Neuroimage (2002) 1.49
In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology (1977) 1.45
Monoclonal antibodies produced in BALB.B10 mice define new antigenic determinants in culture filtrate preparations of Mycobacterium tuberculosis. J Clin Microbiol (1988) 1.44
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol (1997) 1.43
Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care (2000) 1.34
The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler (2011) 1.34
The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med (1993) 1.33
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis of complex protein mixtures. J Immunol Methods (1993) 1.32
ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand (1986) 1.32
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus. Vaccine (1987) 1.25
Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Stand (1987) 1.23
Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care (1997) 1.18
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Control of Ca2+ in rod outer segment disks by light and cyclic GMP. Nature (1983) 1.14
Studies on the differentiation of T lymphocytes in sheep. I. Recognition of a sheep T-lymphocyte differentiation antigen by a monoclonal antibody T-80. Immunology (1983) 1.14
Interactions between the subunits of transducin and cyclic GMP phosphodiesterase in Rana catesbiana rod photoreceptors. J Biol Chem (1990) 1.12
The migration of lymphocytes in the fetal lamb. Eur J Immunol (1979) 1.12
Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis (1988) 1.11
Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting. Ann Thorac Surg (2001) 1.11
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med (2001) 1.11
Scattered-light imaging in vivo tracks fast and slow processes of neurophysiological activation. Neuroimage (2001) 1.10
Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest (2000) 1.09
Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene (2006) 1.09
Bordetella pertussis and chronic cough in adults. Clin Infect Dis (1999) 1.06
Continuous image and electrophysiological recording with real-time processing and control. Methods (2001) 1.04
Antitermination by both the promoter and the leader regions of an Escherichia coli ribosomal RNA operon. Proc Natl Acad Sci U S A (1985) 1.02
Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet (1999) 1.02
Conductivity mapping of biological tissue using diffusion MRI. Ann N Y Acad Sci (1999) 1.02
Bayesian inference applied to the electromagnetic inverse problem. Hum Brain Mapp (1999) 1.00
The interaction between pertussis toxin and 10 monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1987) 1.00
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
T-cell recirculation in the sheep: migratory properties of cells from lymph nodes. Immunology (1982) 0.96
Affinity purification, biological characterization and serological evaluation of defined antigens from Mycobacterium tuberculosis. Trop Med Parasitol (1990) 0.96
Retinotopic organization of human visual cortex: departures from the classical model. Cereb Cortex (1996) 0.96
Lymphocyte recirculation in the sheep fetus. Ciba Found Symp (1980) 0.96
The actions of interferon are potentiated at elevated temperature. Nature (1978) 0.96
Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J Infect Dis (1998) 0.96
Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine (1997) 0.95
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS (2000) 0.95
Bordetella pertussis diagnosed by polymerase chain reaction. APMIS (1994) 0.94
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance. Eur J Hum Genet (2001) 0.93
Susceptibility to diphtheria in populations vaccinated before and after elimination of indigenous diphtheria in Denmark. A comparative study of antitoxic immunity. Acta Pathol Microbiol Immunol Scand C (1987) 0.93
Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand J Infect Dis (1993) 0.93
Efficacy and toxicity of two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus. Dutch AIDS Treatment Group. J Infect Dis (1995) 0.93
Lymphocyte proliferative responses and the occurrence of dermatophilosis in cattle naturally infested with Amblyomma variegatum. Vet Parasitol (1994) 0.93
Collection of lymph from single lymph nodes and the intestines of fetal lambs in utero. Int Arch Allergy Appl Immunol (1979) 0.92
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand C (1986) 0.92
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Vaccine (1996) 0.92
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J Immunol (2001) 0.92
Pharmacokinetics of cefepime in patients with the sepsis syndrome. J Antimicrob Chemother (1993) 0.92
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol (1999) 0.91
Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS (1992) 0.91
The Isopaque-Ficoll method re-evaluated: selective loss of autologous rosette-forming lymphocytes during isolation of mononuclear cells from human peripheral blood. Scand J Immunol (1980) 0.90
Double-antibody sandwich enzyme-linked immunosorbent assay for rapid detection of toxin-producing Corynebacterium diphtheriae. J Clin Microbiol (1987) 0.90
Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine (1993) 0.90
Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS (1997) 0.89
The effect of interferon on lymphocyte-mediated effector cell functions: selective enhancement of natural killer cells. Cell Immunol (1979) 0.89
Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon. J Interferon Res (1981) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods (1996) 0.89
The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol (1991) 0.88
Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1. Infect Immun (1977) 0.88
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine (1998) 0.88
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.87
Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group. J Infect Dis (1997) 0.87
Temporal dynamics of visual-evoked neuromagnetic sources: effects of stimulus parameters and selective attention. Int J Neurosci (1995) 0.87
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis (2000) 0.87
Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine. Clin Diagn Lab Immunol (1995) 0.87
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study. APMIS (1996) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis. J Neuroimmunol (2000) 0.86
Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. Clin Immunol Immunopathol (1998) 0.86